Latest News
SpaceX Reuses IPO Falcon 9 in 32 Days as Starlink Economics Face Scrutiny
SpaceX reuses IPO-day Falcon 9 in 32 days, showcasing rapid turnaround as Starlink economics face market test. Shares remain near offer price.
Oil Majors BP and Shell Cushion FTSE 100 Decline Amid Broader Sell-Off
BP and Shell gains masked a sharper FTSE 100 decline on Tuesday, as oil prices rose on US-Iran tensions. The FTSE 250 fell 0.76%, reflecting broader market weakness.
National Grid Bounces Back 84% from AI Deal Dip as £70 Billion Spending Plan Looms
National Grid shares have recovered 84% of the post-Joulent drop ahead of its AGM, where a £70 billion borrowing limit will be adopted. The company's record capex plan and rising debt are in focus.
Rolls-Royce Shares Tumble 8% as Key Test Looms Ahead of Earnings
Rolls-Royce shares fell 2.2% on Tuesday, pushing the total decline from July 6 to 8%. The stock is now 9.7% below its 52-week high as investors await half-year results on July 30.
Shell Outpaces FTSE as Asset Sales and Oil Rally Reshape ARC Deal
Shell shares rose 1.7% on Tuesday after the company agreed to sell its Indian renewables business, adding to a $5.8 billion disposal program that helps fund its acquisition of ARC Resources.
Standard Chartered Shares Slip on Wealth Management Deal; Analyst Targets Capped
Standard Chartered shares dipped 0.9% on a new wealth management partnership with BlackRock, as analyst targets imply only 4.8% upside before half-year results.
HSBC Shares Slip 9% from High, Analyst Targets Show Limited Upside
HSBC shares fell 0.8% to 1,450.2p, now 8.8% below their July 6 high. The median 12-month analyst target of 1,471.77p offers just 1.5% upside, leaving little room for error ahead of interim results on Aug 4.
BP Shares Surge on $4.2B Earnings Boost and Debt Reduction
BP shares jumped nearly 3% in London after Q2 update flagged $3.5B-$4.2B sequential earnings boost from higher oil prices and refining margins, while net debt fell by up to $3.3B.
AI Trading Bot Promises Daily Returns of 4%, Audit Claims Questioned
MoneySimpler's new AI trading bot claims daily returns up to 4%, but missing audit details and regulatory clarity raise investor concerns.
Agenus Shares Surge 83% on $340M Financing for Key Colon Cancer Trial
Agenus shares surged 83% on news of up to $340M financing for a pivotal colon cancer trial, but three-quarters of that amount hinges on investor warrants.
